Latest Articles

Publication Date
Laparoscopic mesentery-sparing NOSE bowel resection for endometriosis: when and how?

To describe the peri-operative considerations and surgical steps for a laparoscopic segmental resection for colorectal endometriosis, using a nerve-sparing, mesentery-sparing, and natural orifice specimen extraction (NOSE) technique.

Published: July 26, 2025, midnight
Endometriosis-Associated Periodontal Disease: A Large Cohort Perspective Study.

Endometriosis is a chronic estrogen-dependent gynecological disease affecting millions of women worldwide. Besides its well-established impact on reproductive health, emerging evidence suggests a potential association between endometriosis and periodontal disease. …

Published: July 26, 2025, midnight
Case Report: A Challenging Superior Hypogastric Plexus Block in a Patient with Enlarged and Bifid Transverse Processes.

Superior hypogastric plexus block (SHPB) is an established treatment for chronic pelvic pain (CPP). Anatomical variations can significantly complicate interventional pain procedures.

Published: July 26, 2025, midnight
Acupuncture Enhances Fertility Outcomes in Women with PCOS - healthcmi.com

Acupuncture Enhances Fertility Outcomes in Women with PCOS healthcmi.com

Published: July 25, 2025, 11:46 p.m.
Éire Óg get off the Marco with decisive nine point derby triumph - Clare Echo

Éire Óg get off the Marco with decisive nine point derby triumph Clare Echo

Published: July 25, 2025, 9:54 p.m.
Collins & O’Connell help Clonlara step past Sixmilebridge - Clare Echo

Collins & O’Connell help Clonlara step past Sixmilebridge Clare Echo

Published: July 25, 2025, 9:45 p.m.
'This just doesn't affect women it affects their families' - McGettigan frustrated over endometriosis amendment - Clare Echo

'This just doesn't affect women it affects their families' - McGettigan frustrated over endometriosis amendment Clare Echo

Published: July 25, 2025, 6:23 p.m.
FDA extends review period for Bayer's elinzanetant for vasomotor symptoms - Contemporary OB/GYN

FDA extends review period for Bayer's elinzanetant for vasomotor symptoms Contemporary OB/GYN

Published: July 25, 2025, 5:43 p.m.
This Silent Cancer Is Surging—And Certain Women Face the Greatest Risk - NewsBreak: Local News & Alerts

This Silent Cancer Is Surging—And Certain Women Face the Greatest Risk NewsBreak: Local News & Alerts

Published: July 25, 2025, 4:58 p.m.
GSK’s Phase 2 Trial on Dostarlimab for Endometrial Cancer: A Market Game Changer? - TipRanks

GSK’s Phase 2 Trial on Dostarlimab for Endometrial Cancer: A Market Game Changer? TipRanks

Published: July 25, 2025, 4:19 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!